Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Diarrhoea was among the most frequently reported adverse effects in the Phase 2 NEJM trial, occurring in a dose-dependent pattern and most commonly during dose escalation
She said several factors explain their rapid adoption: They significantly reduce appetite and help people eat less without constant hunger Some are FDA-approved for chronic weight management in people who meet eligibility criteria There is growing recognition in healthcare that obesity is a chronic disease, not simply a willpower issue, and may require long-term medical treatment Their popularity also reflects strong public awareness and patient demand, though cost, access, and insurance coverage remain major barriers for many people, Araghi said
Schedule: Patients on either version of Wegovy will gradually increase their dose as tolerated to help minimize side effects and achieve weight loss
The scale of that growth matters
